Valuation: Yunnan Botanee Bio-Technology Group Co.LTD

Capitalization 18.23B 2.65B 2.29B 2.07B 1.99B 3.63B 243B 3.79B 24.52B 9.8B 116B 9.93B 9.72B 417B P/E ratio 2025 *
33.4x
P/E ratio 2026 * 27.8x
Enterprise value 16.94B 2.46B 2.13B 1.93B 1.85B 3.37B 226B 3.52B 22.78B 9.1B 108B 9.23B 9.03B 388B EV / Sales 2025 *
2.99x
EV / Sales 2026 * 2.72x
Free-Float
32.1%
Yield 2025 *
1.32%
Yield 2026 * 1.52%
02-11 Yunnan Botanee Bio-Technology Group Co.Ltd Proposes Dividend for the Third Quarter of 2025 CI
01-12 Yunnan Botanee Bio-Technology Group's shareholder plans to cut stake RE
12-09 Suzhou Zisong Medical Technology Co., Ltd announced that it has received funding from Yunnan Botanee Bio-Technology Group Co.LTD, Beijing Zhongguancun Qihang Venture Capital and other investors CI
25-10-27 Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-29 Macquarie Downgrades Yunnan Botanee Bio-Technology Group to Underperform from Outperform; Price Target is 42 Yuan MT
25-08-27 Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-07-24 Yunnan Botanee Bio-Technology's shareholder to unload shares RE
25-06-29 Shanghai Ruishi Health Technology Co., Ltd. announced that it has received funding from Beijing Jinke Hightech Innovation Ventures Co., Ltd., Sinovation Ventures Enterprise Management Limited, Yaojin Private Equity Fund Management Co., Ltd., Yunnan Botanee Bio-Technology Group Co.LTD, BRV Partners, LLC and other investors CI
25-05-16 Yunnan Botanee Bio-Technology Group Co.LTD Approves Board Appointments CI
25-05-16 Yunnan Botanee Bio-Technology Group Co.Ltd Approves Cash Dividend for the Year 2024 on A Shares, Payable on 30 May 2025 CI
25-05-06 A group of buyers completed the acquisition of 2.50% stake in Yunnan Botanee Bio-Technology Group Co.LTD from Tianjin Sequoia Juye Equity Investment Partnership Enterprise (Limited Partnership), Kunming Zhenli Consulting Co., Ltd. and HongShan for CNY 350 million. CI
25-04-28 Jefferies Adjusts Yunnan Botanee Bio-Technology's Price Target to 42 Yuan From 62 Yuan, Keeps at Hold MT
25-04-25 Yunnan Botanee Bio-Technology Group Co.Ltd Proposes Dividend for the Year 2024 CI
1 day-0.32%
1 week-8.47%
Current month-7.87%
1 month-3.15%
3 months+8.28%
6 months-5.42%
Current year+9.62%
1 week 43.14
Extreme 43.14
47.14
1 month 43.14
Extreme 43.14
49.79
Current year 39.63
Extreme 39.63
49.79
1 year 37.46
Extreme 37.46
51.8
3 years 37.46
Extreme 37.46
138.5
5 years 37.46
Extreme 37.46
289.35
10 years 37.46
Extreme 37.46
289.35
Manager TitleAgeSince
Chief Executive Officer 63 2016-11-30
Director of Finance/CFO 44 2016-11-30
Corporate Officer/Principal 47 2012-06-30
Director TitleAgeSince
Chairman 63 2014-05-31
Director/Board Member 58 2013-09-30
Director/Board Member 50 2012-10-31
Change 5d. change 1-year change 3-years change Capi.($)
-0.32%-8.47%+1.42%-68.66% 2.65B
-0.76%-6.54%+1.93%-1.80% 232B
+6.98%+6.17%+38.01% - 44.05B
-1.94%-6.39%-4.55%+22.91% 18.28B
+1.13%-5.53%+11.79%-52.54% 7.65B
+3.83%-17.07%+12.53%-10.64% 5.32B
+1.81%-13.95%+25.95%+13.00% 4.74B
-0.06%-6.48%-20.28%-49.18% 3.83B
+1.77%-8.05%-28.02%-30.77% 3.02B
+0.36%-10.18%+49.73%+99.47% 2.86B
Average +1.29%-7.96%+8.85%-8.69% 32.48B
Weighted average by Cap. +0.43%-5.60%+7.10%-2.04%

Financials

2025 *2026 *
Net sales 5.67B 823M 711M 644M 619M 1.13B 75.55B 1.18B 7.62B 3.05B 36.2B 3.09B 3.02B 130B 6.22B 902M 780M 707M 678M 1.24B 82.86B 1.29B 8.36B 3.34B 39.7B 3.39B 3.31B 142B
Net income 550M 79.79M 69M 62.48M 59.99M 109M 7.33B 114M 739M 295M 3.51B 299M 293M 12.59B 661M 95.86M 82.9M 75.07M 72.07M 131M 8.8B 137M 888M 355M 4.22B 360M 352M 15.12B
Net Debt -1.29B -187M -162M -147M -141M -257M -17.22B -268M -1.74B -694M -8.25B -704M -689M -29.58B -1.31B -190M -165M -149M -143M -261M -17.48B -272M -1.76B -705M -8.37B -714M -699M -30.02B
Logo Yunnan Botanee Bio-Technology Group Co.LTD
Yunnan Botanee Bio-Technology Group Co LTD is a Chinese company mainly engaged in the production of cosmetics. The Company adopts a sales model based on offline channel sales and online channel sales as the leading factor. The Company's products mainly include creams, skin care lotions, facial masks, essences, lotions and other skin care products and make-up products such as isolation creams, blemish balm (BB) creams, and makeup removers. The Company is also engaged in the research and development, production and sales of skin care-related medical device products, mainly including hyaluronic acid repairing biofilm, hyaluronic acid repairing dressings, mainly used for the protection of skin with damaged barriers after minimally invasive surgery and care.
Employees
3,956
Date Price Change Volume
26-03-04 43.42 ¥ -0.32% 4,015,921
26-03-04 43.56 ¥ -1.13% 4,889,377
26-03-03 44.06 ¥ -3.59% 5,910,920
26-03-02 45.70 ¥ -3.03% 5,404,055
26-02-27 47.13 ¥ +0.88% 3,396,254
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
43.42CNY
Average target price
45.42CNY
Spread / Average Target
+4.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300957 Stock